RHÖN-KLINIKUM AG / Final Results/Quarter ResultsRelease of a Corporate News, transmitted by DGAP - a company of EquityStoryAG.The issuer / publisher is solely responsible for the content of this announcement.
Results for financial year 2008:* Also in the 20th year of its stock market listing, the Company hascomfortably met its forecasts and demonstrated its operating performance* 1.6 million patients treated (+ 6.7%)* Revenues: EUR 2.1 billion (+ 5.2%) * Once again a disproportionate rise in net consolidated profit to EUR122.6 million (+ 10.3%)* EBITDA climbs to EUR 262.8 million (+ 5.4%) * EBIT increased to EUR 172.1 million (+ 9.3%) * Dividend proposal: EUR 0.35 per ordinary shareQ1 2009 results:* Good start into new financial year* Over 450,000 patients treated already in the first quarter (+ 10.3%) * Revenues rise to EUR 559.1 million (+ 7.4%) * Net consolidated profit increased to EUR 30.7 million (+ 3.7%)* EBITDA climbs to EUR 67 million (+ 4.4%)* EBIT of EUR 42.8 million (- 2.1%) slightly below previous year's leveldue to negative one-off effectsForecast for the further course of 2009: * Environment for the hospital market still challenging* Forecast for 2009 reaffirmed: revenues of EUR 2.3 billion, profit of EUR130 million within a fluctuation range of plus or minus EUR 5 million basedon risks and opportunitiesBad Neustadt a. d. Saale/Frankfurt am Main, 23 April 2009 ----- At itsannual Results Press Conference held today in Frankfurt am Main, the Boardof Management of RHÖN-KLINIKUM AG confirmed the trend figures alreadypublished in February. 'We have met our forecast for 2008, expanded ourmedical offering and comfortably maintained our growth course', saidWolfgang Pföhler, chairman of the Board of Management of the hospitalgroup. Results for financial year 2008 In financial year 2008, a total of 1,647,972 (+ 6.7%) patients were treatedat the Group's 48 hospitals and 20 medical care centres (MVZs). Revenuesrose to EUR 2.13 billion (+ 5.2%). With the net consolidated profit of EUR122.6 million (+10.3%), the Group has once again clearly demonstrated itsrestructuring expertise. EBITDA (earnings before interest, depreciation/amortisation and tax) roseto EUR 262.8 million (+ 5.4%). EBIT (operating result) climbed to EUR 172.1million (+ 9.3%). Operating cash flow rose to EUR 213.8 million (+ 11.9%).As at 31 December 2008, the number of employees at the Group (by headcount)was 33,679 (+ 4.5%). Earnings per ordinary share stood at EUR 1.13(previous year: EUR 1.03). As the Group's biggest subsidiary, Universitätsklinikum Gießen und MarburgGmbH raised its earnings as planned to EUR 2.2 million. 'At both sites wehave made extensive investments in good medical care. Because of the highpatient demand for our services, we have also increased our staffing ofdoctors and nurses here', explained Gerald Meder, deputy chairman of theBoard of Management.On 10 June 2009, the Board of Management and the Supervisory Board willpropose a dividend of EUR 0.35 (previous year: EUR 0.28) per ordinarynon-par share with dividend entitlement (DE 0007042301; 103,680,000 non-parshares).Q1 2009 resultsThe Management is pleased with the start the Company has made intofinancial year 2009. 'We have got off to a good start into the new year',emphasised Wolfgang Pföhler.Already in the first three months, the Group treated 452,319 patients (+10.3%). Revenues rose to EUR 559.1 million (+ 7.4%). At EUR 30.7 million (+3.7%), net consolidated profit for the first time exceeded EUR 30 millionafter the first quarter.EBITDA climbed to EUR 67.0 million (+ 4.4%) EBIT stood at EUR 42.8 million(- 2.1%), which is slightly below the level of the previous year. Thisstems among other things from the first-time consolidation of the hospitalsin Warburg and Nordenham. Operating cash flow is at EUR 57.6 million (+10.8%). At the end of the first quarter, earnings per share stood at EUR0.28 (+ 3.7%). As at 31 March 2009, the Group had 33,958 employees (+5.1%).'We achieved our targets for 2008 and have continued our growth in thefirst quarter of 2009. Our financial structures are stable and orientedlong-term' explained Dr. Erik Hamann, the Company's CFO.Forecast for the further course of 2009'Faced with one of the most severe economic and financial crises indecades, many industries are bracing themselves for a steep slump ingrowth. The situation in the healthcare industry as a largely non-cyclicalsector has so far remained stable', Pföhler emphasised.With the German Hospital Finance Reform Act having entered into force, theregulatory framework for the hospital market has been largely mapped outfor the current year. The Hospital Finance Reform Act will essentiallyresult in the existing remuneration system for inpatient services beingpreserved.'We have some challenges to tackle', said Pföhler, 'and will cushion theunexpected burdens from the prolonging of the convergence phase by takingspecific counter-measures. Over the past years we have proven that we knowhow to cope with changes in the regulatory environment resulting from newlegislation. And that is what we plan to do in 2009 also.'The Management confirms the forecast for 2009. The Group will achieverevenues of EUR 2.3 billion and a net consolidated profit of EUR 130million within a possible fluctuation range of plus or minus EUR 5 million.'We are optimistic that we will achieve our growth targets and willsteadfastly continue our transformation from classic hospital operator tointegrated healthcare provider', stated Wolfgang Pföhler inclosing.Dr. Irmgard Stippler Board Member for Communication and ITSchlossplatz 197616 Bad Neustadt a. d. SaaleTel.: +49 (0)9771 65-1321Fax: +49(0)9771 65-1306E-Mail: kommunikation@rhoen-klinikum-ag.com23.04.2009 Financial News transmitted by DGAP
 Language: EnglishIssuer: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale DeutschlandPhone: +49 (0)9771 - 65-0Fax: +49 (0)9771 - 97 467E-mail: fire.ir@rhoen-klinikum-ag.comInternet: www.rhoen-klinikum-ag.comISIN: DE0007042301WKN: 704230Indices: MDAXListed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service